CRADLE-1 Seeks to Rewrite the Economics of Protein Engineering
Drug discovery has two big machine learning stories: The first — de novo design, where AI conjures entirely new protein binders from scratch — has...
Machine learning applied to scientific work, from foundation models for biology to AI agents that run experiments.
62 articles
Drug discovery has two big machine learning stories: The first — de novo design, where AI conjures entirely new protein binders from scratch — has...
Amazon Web Services (AWS) today introduced BioDiscovery, a platform designed to unify biological data processing, AI model development, and scalable experimentation workflows within a single...
The race to reinvent drug discovery is accelerating—and Medra.ai is quickly emerging as a key player. Following a $52 million funding round, the company is...
A new pipeline marries de novo protein design with robotic sample prep and NMR spectroscopy — producing atomic-resolution data at a pace that was unthinkable...
Chem-Impex launches a 6-week fellowship for early-career peptide researchers — offering mentorship, visibility, and a chance to advance their science.
If you thought your not so comfortable wet lab jobs were safe, think again. The launch of the Cloud Lab platform by Ginkgo Bioworks represents...
Eubiota launches the first modular agentic AI for autonomous microbiome discovery — combining reinforcement learning with experimental validation.
This open-source project gives AI coding assistants superpowers for scientific research — from drug discovery to genomic analysis.